Hiroyuki Sakashita Selected Research

Bevacizumab (Avastin)

1/2014

Neurological Toxicity in Metastatic Colorectal Cancer Patients Treated with Modified FOLFOX6 Plus Bevacizumab.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hiroyuki Sakashita Research Topics

Disease

7	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2013
7	Neoplasms (Cancer) 01/2020 - 10/2008
4	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2022 - 09/2015
4	Lung Neoplasms (Lung Cancer) 01/2021 - 12/2013
3	Neoplasm Metastasis (Metastasis) 01/2020 - 11/2007
2	Idiopathic Pulmonary Fibrosis 11/2018 - 07/2003
2	Dyspnea (Shortness of Breath) 01/2018 - 07/2011
2	Extrinsic Allergic Alveolitis (Hypersensitivity Pneumonitis) 01/2018 - 09/2015
2	Pulmonary Tuberculosis 01/2013 - 07/2011
2	Colonic Neoplasms (Colon Cancer) 10/2008 - 02/2008
1	Liver Diseases (Liver Disease) 06/2020
1	Sarcoma (Soft Tissue Sarcoma) 01/2020
1	Thymoma (Thymic Carcinoma) 01/2020
1	Lung Injury 11/2019
1	Adenocarcinoma of Lung 11/2018
1	Vascular Diseases (Vascular Disease) 09/2015
1	Connective Tissue Diseases (Connective Tissue Disease) 09/2015
1	Colorectal Neoplasms (Colorectal Cancer) 01/2014
1	Acute Kidney Injury (Acute Renal Failure) 01/2013
1	Fever (Fevers) 07/2011
1	Edema (Dropsy) 07/2011
1	Hemorrhage 07/2011
1	Thromboembolism 07/2011
1	Thrombosis (Thrombus) 07/2011
1	Abdominal Pain (Pain, Abdominal) 11/2010
1	Fistula 11/2010
1	Cutaneous Fistula 11/2010
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 11/2010
1	Eosinophilia 08/2009
1	Stomach Neoplasms (Stomach Cancer) 10/2008
1	Bird Fancier's Lung 09/2004
1	Disease Progression 07/2003

Drug/Important Bio-Agent (IBA)

3	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2020
2	Carboplatin (JM8)FDA LinkGeneric 01/2022 - 01/2013
2	alectinibIBA 01/2020 - 01/2017
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2018 - 07/2003
2	AntigensIBA 01/2018 - 09/2015
1	130-nm albumin-bound paclitaxelIBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Tyrosine Kinase InhibitorsIBA 01/2021
1	Therapeutic UsesIBA 01/2020
1	NivolumabIBA 01/2020
1	Pharmaceutical PreparationsIBA 11/2019
1	penicillamine-glutathione mixed disulfideIBA 11/2018
1	Pulmonary Surfactants (Pulmonary Surfactant)IBA 11/2018
1	AntibodiesIBA 01/2018
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2018
1	CollagenIBA 09/2015
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2014
1	Bevacizumab (Avastin)FDA Link 01/2014
1	Messenger RNA (mRNA)IBA 12/2013
1	Levofloxacin (Levaquin)FDA Link 01/2013
1	Rifampin (Rifampicin)FDA LinkGeneric 01/2013
1	Antitubercular AgentsIBA 07/2011
1	fibrin fragment D (D-dimer)IBA 07/2011
1	Sunitinib (Sutent)FDA Link 11/2010
1	Phosphotransferases (Kinase)IBA 11/2010
1	Imatinib Mesylate (Gleevec)FDA Link 11/2010
1	Immunoglobulin E (IgE)IBA 08/2009
1	Matrix Metalloproteinase 14 (MT1-MMP)IBA 10/2008
1	RNA (Ribonucleic Acid)IBA 10/2008
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 10/2008
1	Indicators and Reagents (Reagents)IBA 10/2008
1	Complementary DNA (cDNA)IBA 10/2008
1	Butyric Acid (Butanoic Acid)IBA 10/2008
1	Biological ProductsIBA 02/2008
1	Methylcellulose (BFL)IBA 09/2004
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 07/2003

Therapy/Procedure

6	Therapeutics 01/2021 - 07/2003
6	Drug Therapy (Chemotherapy) 02/2020 - 11/2007
1	Immunotherapy 11/2019
1	Lasers (Laser) 12/2013
1	Adjuvant Chemotherapy 01/2013
1	Subcutaneous Injections 10/2008